Skip to main content


SHOW Co-Chairs

Wendy Lam, BSc. (Pharm), MD, FRCPC

Hematologist and Medical Oncologist
Burnaby Hospital Regional Cancer Center
Director, BC Community Oncology Trialists
Burnaby, BC

Dr. Wendy Lam is a hematologist and medical oncologist at the Burnaby Hospital Regional Cancer Centre.

She received her B.Sc (Pharmacy) at Dalhousie University and her MD from University of British Columbia. She then completed her Internal Medicine residency at UBC and Hematology fellowship at McMaster University.

She is the Founding Director of the British Columbia Community Oncology Trialists (BC Cot), which is a collaborative group of oncologists and hematologists involved in clinical research.

Her other interests include education of patients through meeting with patient groups. She has also been instrumental in organizing meetings for continued medical education.

She is Director of the Society of Hematology and Oncology of BC at British Columbia Medical Association.

She is Director of the Society of Hematology and Oncology of BC at British Columbia Medical Association

David Liu, MD, FRCPC, FSIR

Associate Professor, Department of Radiology, Faculty of Medicine, University of British Columbia
Associate Professor, School of Biomedical Engineering, Faculty of Applied Sciences, University of British Columbia
Voluntary Professor, Department of Interventional Radiology, Miller School of Medicine, University of Miami
Vancouver, BC

Dr. David M Liu MD is a board certified in both Canada and the US, practicing at the Vancouver General Hospital, University of British Columbia Hospital and the BC Cancer Agency with a cross appointment in the Department of Surgery. Dr. Liu received his medical degree from University of Toronto, completed his radiology residency at University of British Columbia, Interventional Radiology fellowship at Northwestern Memorial Hospital, and has practiced in both the US and Canada.

In addition to benchside and clinical research in the fields of novel embolic platforms, ablative technologies and cancer related thromboembolic disease, Dr. Liu maintains an interventional oncology practice incorporating all aspects of embolization, ablation, venous access, and palliative therapy in all organ systems. He is the co-founder and co-chair of the international liver cancer symposium, SHOW, and has been credited with 7 book chapters, over 70 publications, and over 100 invited lectures around the world. Dr. Liu an active member of the interventional radiology community as recognized through his induction as a Fellow of the Society of Interventional Radiology, and has been awarded the CIRA award from the Canadian Association of Interventional Radiology (CAIR) in recognition of his extraordinary contribution to the practice of IR in Canada and worldwide.

Dr. Liu holds numerous academic appointments including:

Associate Professor, Faculty of Medicine, Department of Radiology, University of British Columbia, Vancouver, Canada

Associate Professor, Faculty of Applied Sciences, School of Biomedical Engineering, University of British Columbia, Vancouver, Canada

Voluntary Professor, Miller School of Medicine, Department of Interventional Radiology, Miami, USA

Andrew Kennedy, MD, FACRO

Physician in Chief, Radiation Oncology, Sarah Cannon
Director, Radiation Oncology Research, Sarah Cannon Research Institute
Sarah Cannon Cancer Center
Nashville, TN

Dr. Kennedy joined Sarah Cannon in 2012 as the Physician in Chief, Radiation Oncology and Director, Radiation Oncology Research at Sarah Cannon Research Institute where he is responsible for strategic development of radiation oncology services for HCA Healthcare and development of radiation oncology research program within Sarah Cannon to complement the world-class medical oncology program. Dr. Kennedy is a graduate of the Loma Linda School of Medicine in California, and completed his residency at The University of North Carolina at Chapel Hill.

He is an internationally renowned radiation oncologist specializing in gastrointestinal cancers, as well as cancers of the breast and lung. Nationally, he served as a member of the Board of Chancellors for the American College of Radiation Oncology and is a Fellow of the College. He has been selected yearly since 2009 as one of America’s Best Doctors (top 5 percent of U.S.), and was inducted into Alpha Omega Alpha (AOA) Honor Society as a faculty member in 1999.


Head, Liver Transplant Program
Head, Hepatopancreatobiliary Surgery
Vancouver General Hospital
Clinical Associate Professor
University of British Columbia
Vancouver, BC

Dr. Peter Kim is a liver transplant and a hepatopancreatobiliary (HPB) surgeon at the Vancouver General Hospital and an associate clinical professor of the Department of Surgery, University of British Columbia. He is the current head of the liver transplant and the HPB surgery program at the Vancouver General Hospital.

Dr. Kim received his medical degree from the University of Western Ontario in London, Ontario, Canada. He completed his general surgery residency and Masters of Sciences degree at the University of British Columbia. His research work focused on differentiating embryonic stem cells into insulin producing cells to treat diabetes. He subsequently completed his abdominal transplant surgery fellowship at Baylor University Medical Center, Dallas, Texas, followed by HPB surgery fellowship at the University of Toronto.

After his training, Dr. Kim worked at the Baylor University Medical Center as the assistant director of living donor liver transplantation for 5 years before returning to the Vancouver General Hospital to join the liver transplantation team. His clinical practice includes liver transplantation and hepatopancreatobiliary surgery.

Dr. Kim is an author of over 60 publications and 8 book chapters. His research interests include studying the importance of blood flow to the liver in liver transplantation, bile duct complications in liver transplantation and complex surgical resections in pancreas cancer surgery.

Medical Oncology

Howard Lim, MD, PhD, FRCPC

Clinical Associate Professor
Faculty of Medicine, UBC
Medical Oncologist
BC Cancer- Vancouver Centre
Vancouver, BC

Howard Lim is a Medical Oncologist at B.C Cancer – Vancouver Centre and Clinical Associate Professor in the Faculty of Medicine at the University of British Columbia.  He specializes in gastrointestinal malignancies and is actively involved in clinical trials, ethics and genomic based research.

Daniel Renouf, MD, MPH, FRCPC

Associate Professor, University of British Columbia
Medical Oncologist
Executive Medical Director
BC Cancer, Vancouver Centre
Vancouver, BC

Daniel Renouf is a medical oncologist and the Executive Medical Director at BC Cancer, Vancouver Centre.  He is an Associate Professor at the University of British Columbia, Department of Medicine.

He received his Doctor of Medicine from the University of Alberta and completed his internal medicine and medical oncology training at the University of British Columbia and BC Cancer.  He undertook further training in early drug development and gastrointestinal oncology at Princess Margaret Hospital and the University of Toronto, and obtained a Masters of Public Health from Harvard University.

Daniel’s research interests include developmental therapeutics, genomics, and biomarker development within gastrointestinal cancers, with a focus on pancreatic cancer.  He is the leader of the BC Cancer Phase I program, the BC Cancer GI Tumour Group chair, the Co-Director of Pancreas Centre BC and is the Co-chair of the Canadian Cancer Trials Group Pancreatic Cancer disease group.

Vladimir Marquez, MDCM, M.Sc, FRCPC

Vancouver General Hospital
Vancouver, BC

Dr. Vladimir Marquez is a member of the division of Gastroenterology at the Vancouver General Hospital. He complete his undergraduate and medical training as well as his Masters in Epidemiology at McGill University and residency training at Laval University. His expertise include liver transplantation, complications of portal hypertension and vascular liver disorders. He is also an active member of the liver tumor board at Vancouver General Hospital.

Benjamin A. Weinberg, MD, FACP

Associate Professor of Medicine, Division of Hematology and Oncology
Attending Physician, MedStar Georgetown University Hospital
Gastrointestinal Medical Oncologist
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center

Dr. Weinberg is an Associate Professor of Medicine and Attending Physician specializing in gastrointestinal medical oncology and sarcoma. Dr. Weinberg is focused on developing new therapies for colorectal and pancreatic cancers by translating research from animal models into early phase clinical trials in humans. He also studies young patients with colorectal cancer in order to understand the dramatic rise in incidence of left-sided colon and rectal cancers in this population.

Dr. Weinberg obtained his undergraduate degree in biomedical science at the University of Pennsylvania in 2007 and his MD at the Keck School of Medicine of the University of Southern California in 2011. He completed his post-graduate medical training at MedStar Georgetown University Hospital with a residency in internal medicine in 2014 and a fellowship in hematology and oncology in 2017 where he served as the Chief Fellow from 2016 to 2017.

Interventional Radiology

Robert Lewandowski, M.D., FSIR

Professor of Radiology, Medicine, and Surgery
Feinberg School of Medicine, Northwestern University
Director, Interventional Oncology
Northwestern University Robert H. Lurie Comprehensive Cancer Center
Evanston, IL

Robert J. Lewandowski, M.D., FSIR, is a Professor of Radiology, Medicine, and Surgery in the Feinberg School of Medicine at Northwestern University. He serves as the Director of Interventional Oncology at the Northwestern University Robert H. Lurie Comprehensive Cancer Center. Dr. Lewandowski joined the staff at Northwestern in 2006 upon completion of his fellowship training in Vascular and Interventional Radiology. Dr. Lewandowski is a practicing interventional radiologist who specializes in liver-directed therapy. Based on his clinical oncology program, he has authored or co-authored > 150 articles for peer-reviewed journals on the application of liver-directed therapies for patients with gastrointestinal malignancies.

Dr. Lewandowski also performs pre-clinical oncology research in the Northwestern University Interventional Oncology Laboratory and Center for Translational Imaging. In this capacity, he is developing and evaluating novel oncology therapeutics, delivery mechanisms, and imaging modalities. Dr. Lewandowski’s work has been supported by the National Institute of Health, American Cancer Society, the Society of Interventional Radiology Foundation, and industry collaboration via the investigator-initiated trial mechanism.

Govindarajan (Raj) Narayanan, MD

Interventional Radiologist,  Miami Cardiac and Vascular Institute
Chief of Interventional Oncology, Miami Cancer Institute
Miami, FL

Dr. Narayanan is an Interventional Radiologist at the Miami Cardiac and Vascular Institute and the Chief of Interventional Oncology at the Miami Cancer Institute. Dr. Narayanan is board-certified in diagnostic radiology and holds a Certificate of Added Qualification in interventional radiology. 


Most recently, he served as medical director of Interventional Radiology at University of Miami Hospital and Clinics, and as the founding chairman of the Department of Interventional Radiology at the University Of Miami Miller School Of Medicine, where he also served as a Professor of interventional Radiology.


Dr. Narayanan’s primary clinical research interests include pancreatic, liver and colon cancer. He is widely published in such high-impact medical journals as Cancer, Journal if Vascular and Interventional Radiology and Cardiovascular and Interventional Radiology and serves as a reviewer and editor for several scientific publications. He has authored text book chapters and is an invited faculty member and speaker at national and international scientific meetings. 

Jason Wong, MD

Clinical Associate Professor,
Cumming School of Medicine, University of Calgary
Interventional Radiologist
Partner, EFW Radiology
Tertiary Care Hospital, Foothills Medical Centre
Calgary, AB .

Dr. Jason Wong is an Interventional Radiologist working as a partner of EFW Radiology. He is based at the tertiary care hospital, Foothills Medical Centre, in Calgary and is a Clinical Associate Professor at the Cumming School of Medicine at the University of Calgary.

Dr. Wong is a Past President for the Canadian Association for Interventional Radiology (CAIR) and has been on the CIRA board since 2011. He continues to serve on many other local and provincial committees. He is also a past board member for the Canadian Association of Radiologists (CAR).

Dr. Wong is an elected as a Fellow of the Society of Interventional Radiology (SIR), and also a fellow of the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) one of the highest honours bestowed to both organizations.

Additionally, Dr. Wong is involved in teaching medical students, residents, and fellows at the University of Calgary. Dr. Wong was the fellowship director for the Department of Radiology of the University of Calgary from 2008-2014, and has been an active member of its Residency Program Committee since 2007. Dr. Wong is a current examiner for Diagnostic Radiology at the Royal College of Physicians and Surgeons of Canada.

Dr. Wong completed an Interventional Radiology fellowship at Stanford University School of Medicine, in California, where he also did a mini cardiac imaging fellowship.

Dr. Wong’s practice is focused on interventional oncology treatments (and brought the Y90/TARE program to Calgary). He is also interested in venous disease, women’s health, and cardiovascular imaging.

Dr. Wong enjoys spending time with his wife Seline and their two sons, Logan and Luke. The family can be seen wake surfing, skiing, and golfing.

Surgical Oncology

Ian D McGilvray MD, PhD

Professor of Surgery, University of Toronto
Head, HepatoPancreaticoBiliary Surgical Oncology
Director, Toronto Video Atlas of Surgery (
University Health Network
Toronto, ON

Dr McGilvray is a professor of surgery at the University of Toronto. He is a liver and pancreas oncology and transplant surgeon, the head of HPB Surgical Oncology at the Toronto General Hospital and the founding director of the Toronto Video Atlas of Surgery. His laboratory focuses on outlining the immune microenvironment of the human liver in health and disease.

Jean-Nicolas Vauthey, MD, FACS

Chief, Hepato-Pancreato-Biliary Section
Dallas/Fort Worth Living Legend Chair, Cancer Research, Department of Surgical Oncology, Division of Surgery
The University of Texas MD Anderson Cancer Center
Houston, TX

Dr. Vauthey is Chief of the Hepato-Pancreato-Biliary section and Dallas/Fort Worth Living Legend Chair for Cancer Research, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center. His clinical research has focused on methods to measure and to improve outcome after hepatic resection for hepatobiliary malignancies. He has co-authored more than 600 publications in peer-reviewed journals (h-index, 116) and more than 100 reviews and book chapters in major textbooks. Dr. Vauthey is editor of major textbooks devoted to the treatment of liver diseases. Dr. Vauthey is Chair of The American Joint Committee on Cancer Hepatobiliary and Pancreas Task Force for the 8th Edition of the Manual for Staging Cancer. Dr. Vauthey is the current President of the Society for Surgery of the Alimentary Tract and the past President of the Americas Hepato-Pancreato-Biliary Association. Dr. Vauthey is on the editorial board of the Journal of the American College of Surgeons, Surgery, Annals of Surgery, Annals of Surgical Oncology and the Journal of Gastrointestinal Surgery.

Sean Cleary, MD

Division Chair, Hepatobiliary and Pancreas Surgery
Co-Deputy Director (Disease Groups) and Chair of the Hepatobiliary and Pancreatic Disease Group, Mayo Clinic Comprehensive Cancer Center
Consultant, Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic
Professor of Surgery, Mayo Clinic College of Medicine and Science
Rochester, Minnesota

Sean P. Cleary, M.D., is the Division Chair of Hepatobiliary and Pancreas Surgery, co-Deputy Director (Disease Groups) and Chair of the Hepatobiliary and Pancreatic Disease Group of the Mayo Clinic Comprehensive Cancer Center and a consultant in the Division of Hepatobiliary and Pancreas Surgery Department of Surgery at Mayo Clinic in Rochester, Minnesota.  Dr. Cleary holds the academic rank of Professor of Surgery, Mayo Clinic College of Medicine and Science.

Dr. Cleary earned his B.Sc. with honors at Queens University in Kingston, Ontario, and his M.D. at the University of Western Ontario in London, Ontario. He completed a residency in general surgery at the University of Toronto, where he also completed the Clinical Investigator Program earning his Master of Science degree.  He continued his training at the University of Toronto, completing a fellowship in hepatobiliary oncology and transplantation surgery and earning his Master of Public Health in community health and epidemiology.

Dr. Cleary served on the staff of University Health Network at the University of Toronto prior to joining Mayo Clinic in March 2017.  His clinical interests include the surgical treatment of pancreatic, hepatic and biliary malignancies with a specific focus on minimally invasive approaches to these cancers.  His research interests include the genetic epidemiology of pancreatic and hepatocellular cancers.  He is frequently invited to give presentations on his work to both national and international audiences and has authored numerous journal articles, book chapters, abstracts and other written publications.

In addition to his clinical and research activities, Dr. Cleary is active in education and has provided mentorship to many residents and fellows, among others.  He is a recipient of the Frank Milles Teaching Award and Nicolas Colapinto Teaching Award, conferred by the University of Toronto.

Dr. Cleary is a member of the American Surgical Association as well as a fellow and member of Board of Governors of the American College of Surgeons. He is currently the President of the Canadian Association of General Surgeons and President-elect of the Americas Hepato-Pancreato-Biliary Association.

Radiation Oncology

Kyle Cuneo, MD

Associate Professor, Radiation Oncology
University of Michigan
Detroit, MI

Dr. Cuneo performs basic science, translational, and clinical research at the University of Michigan. His research focuses on the development of novel therapeutic approaches and biomarker discovery in gastrointestinal cancers. He serves as the principal investigator on clinical trials in pancreatic cancer, hepatocellular carcinoma, and colorectal cancer.

Navesh K. Sharma, DO, PhD, FACRO

Medical Director,
WellSpan Radiation Oncology
Reading, PA

Dr. Sharma is the Medical Director for Radiation Oncology in the WellSpan Health System in southern Pennsylvania. He was preciously a Professor of Radiation Oncology in the Pennsylvania State University College of Medicine. Dr. Sharma has been well published in the field of gastrointestinal malignancies with a particular focus in liver directed applications of radiation. He was the US principal investigator for the FOXFIRE Global International trial.